Intrahypothalamic injection of cannabidiol enhances the extracellular levels of adenosine in nucleus accumbens in rats (abst–2014)
Results of exercise stress to the endocannabinoid process in individuals below field circumstances (abst–2011)
Persistent cannabis dependence and alcohol dependence symbolize challenges for midlife economic and social issues: A longitudinal cohort research (abst–2016)
Cannabinoid receptor-distinct mechanisms to ameliorate agony in sickle cell anemia by using inhibition of mast mobile activation and neurogenic inflammation (backlink to PDF–2015)
Characterisation of cannabinoid composition in a various Cannabis sativa L. germplasm collection (link to PDF – 2015)
See how Mayo Clinic investigate and clinical trials advance the science of medicine and boost client care.
Reduced CB receptor binding and cannabinoid signaling in 3 Mind areas of a rat model of schizophrenia (abst–2016)
Binding of the tritiated inverse agonist to cannabinoid CB1 receptors is enhanced in patients with schizophrenia (complete–2012)
The Alzheimers Treatment Cannabis development of Alzheimer’s is affiliated with the formation of plaques inside the brain. These plaques type every time a compound often called beta-amyloid is introduced from brain cells into grey matter.
Endocannabinoid process modulator use in every day scientific practice in the UK and Spain (abst–2013)
No smoke, no fire: What the initial literature suggests concerning vapourized cannabis and respiratory threat (whole–2015)
Inhibition of diacylglycerol lipase (DAGL) while in the lateral hypothalamus of rats helps prevent the increase in REMS and foods ingestion induced by PAR1 stimulation (abst–2014)
Complementary and alternative healthcare therapies in various sclerosis-the american academy of neurology suggestions: a commentary (complete–2014)
Focusing on the cannabinoid pathway boundaries the development of fibrosis and autoimmunity in the mouse model of systemic sclerosis (complete–2010)